Literature DB >> 32401053

Variability in the Laboratory Measurement of Cytokines: A Longitudinal Summary of a College of American Pathologists Proficiency Testing Survey.

Vijaya Knight1, Thomas Long1, Qing H Meng1, Michael A Linden1, Daniel D Rhoads1.   

Abstract

CONTEXT.—: The measurement of cytokines in clinical laboratories is becoming an increasingly routine part of immune monitoring when administering biologic and cell-based immunotherapies and also for clinical assessment of inflammatory conditions. While a number of commercial assays and platforms are available for cytokine measurement, there is currently little standardization among these analytical methods. OBJECTIVE.—: To characterize the variability and comparability among cytokine testing platforms that are commonly used in clinical laboratories. DESIGN.—: We analyzed data for 4 cytokines (interleukin [IL]-1, IL-6, IL-8, and tumor necrosis factor-alpha [TNF-α]) from 6 College of American Pathologists cytokine surveys administered from 2015 to 2018. Analyses interrogated variability between testing methods and variability within each laboratory across the mailings. RESULTS.—: Significant variability was noted across methods with analysis of IL-1 showing the least variability and IL-6, IL-8, and TNF-α varying between methods to a greater extent. Intralab variability was also significant with TNF-α measurements again showing the greatest variability. CONCLUSIONS.—: This retrospective analysis of College of American Pathologists proficiency testing data for cytokine measurement is the largest method comparison to date, and this study provides a description of the variation of cytokine measurement across methods, across laboratories, and within laboratories. Serial monitoring of cytokines should preferentially be performed by the same method within the same laboratory.

Entities:  

Year:  2020        PMID: 32401053     DOI: 10.5858/arpa.2019-0519-CP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Interlaboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program.

Authors:  Danyel H Tacker; Christine Bashleben; Thomas C Long; Elitza S Theel; Vijaya Knight; Kamran Kadkhoda; Daniel D Rhoads; Michael A Linden; Susan L Fink
Journal:  Arch Pathol Lab Med       Date:  2021-05-01       Impact factor: 5.534

2.  Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness.

Authors:  Eric D Morrell; Pavan K Bhatraju; Neha A Sathe; Jonathan Lawson; Linzee Mabrey; Sarah E Holton; Scott R Presnell; Alice Wiedeman; Carolina Acosta-Vega; Mallorie A Mitchem; Ted Liu; Xin-Ya Chai; Sharon Sahi; Carolyn Brager; Marika Orlov; Sana S Sakr; Anthony Sader; Dawn M Lum; Neall Koetje; Ashley Garay; Elizabeth Barnes; Gail Cromer; Mary K Bray; Sudhakar Pipavath; Susan L Fink; Laura Evans; S Alice Long; T Eoin West; Mark M Wurfel; Carmen Mikacenic
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-05-24       Impact factor: 6.011

3.  Complex biological patterns of soluble cytokines and CD163 in childhood necessitating age-specific reference intervals for evidence-based clinical interpretation.

Authors:  Lusia Sepiashvili; Zaman Alli; Mary Kathryn Bohn; Alexandra Hall; Amir Karin; Kazunori Murata; Khosrow Adeli
Journal:  Clin Biochem       Date:  2021-09-09       Impact factor: 3.625

4.  Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval-FASTER Approval.

Authors:  Aidan M Kirkham; Adrian J M Bailey; Madeline Monaghan; Risa Shorr; Manoj M Lalu; Dean A Fergusson; David S Allan
Journal:  Stem Cells Transl Med       Date:  2022-07-20       Impact factor: 7.655

5.  Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease.

Authors:  Siddhee A Sahasrabudhe; Marcia R Terluk; Kyle D Rudser; James C Cloyd; Reena V Kartha
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

6.  Challenges in interpreting cytokine data in COVID-19 affect patient care and management.

Authors:  Stephen Y Wang; Takehiro Takahashi; Alexander B Pine; William E Damsky; Michael Simonov; Yanhua Zhang; Elizabeth Kieras; Christina C Price; Brett A King; Mark D Siegel; Gary V Desir; Alfred I Lee; Akiko Iwasaki; Hyung J Chun
Journal:  PLoS Biol       Date:  2021-08-06       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.